Redmile Group, LLC

Position in PRME — Prime Medicine, Inc.

CIK 1425738 Larkspur, CA

Position in PRME

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$5,127,742

-$408,353 QoQ

Shares Held

1,389,632

-12.6% QoQ

Ownership

0.766%

of shares outstanding

% of Portfolio

0.34%

of 13F equity value

Holder Rank

#19

of 187 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Redmile Group, LLC holds $1,454,356,867 across 35 Biotechnology names. PRME ranks #29 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SRRK	Scholar Rock Holding Corp	4,311,092	$237,110,060
2	KRYS	Krystal Biotech, Inc.	632,005	$234,897,298
3	STOK	Stoke Therapeutics, Inc.	3,945,920	$129,110,502
4	IMNM	Immunome Inc.	4,911,590	$104,076,592
5	NRIX	Nurix Therapeutics, Inc.	4,073,787	$98,830,072
6	ABSI	Absci Corp	6,739,675	$78,112,833
7	ANNX	Annexon, Inc.	11,869,877	$67,776,997
8	RGNX	REGENXBIO Inc.	4,368,804	$52,338,271

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,127,742	1,389,632	-12.6%	Shares	Sole	2026-08-14
2026-03-31	$5,536,095	1,590,832	+1726.1%	Shares	Sole	2026-05-15
2025-09-30	$482,633	87,118	-95.8%	Shares	Sole	2025-11-14
2025-06-30	$5,123,644	2,074,350	0.0%	Shares	Sole	2025-08-14
2025-03-31	$4,127,956	2,074,350	0.0%	Shares	Sole	2025-05-15
2024-12-31	$6,057,102	2,074,350	0.0%	Shares	Sole	2025-02-14
2024-09-30	$8,027,734	2,074,350	0.0%	Shares	Sole	2024-11-14
2024-06-30	$10,662,159	2,074,350	0.0%	Shares	Sole	2024-08-14
2024-03-31	$14,520,450	2,074,350	+56.6%	Shares	Sole	2024-05-15
2023-12-31	$11,733,741	1,324,350	0.0%	Shares	Sole	2024-02-14
2023-09-30	$12,634,299	1,324,350	0.0%	Shares	Sole	2023-11-14
2023-06-30	$19,401,727	1,324,350	-33.5%	Shares	Sole	2023-08-14
2023-03-31	$24,511,968	1,992,843	-9.8%	Shares	Sole	2023-05-15
2022-12-31	$41,049,723	2,209,350	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.